Cargando…
Emerging SARS-CoV-2 B.1.621/Mu variant is prominently resistant to inactivated vaccine-elicited antibodies
Autores principales: | Xie, Xiaochun, Han, Jian-Bao, Ma, Guanqin, Feng, Xiao-Li, Li, Xiaohong, Zou, Qing-Cui, Deng, Zhong-Hua, Zeng, Jianxiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Science Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645883/ https://www.ncbi.nlm.nih.gov/pubmed/34704423 http://dx.doi.org/10.24272/j.issn.2095-8137.2021.343 |
Ejemplares similares
-
Characterization of the SARS-CoV-2 B.1.621 (Mu) variant
por: Halfmann, Peter J., et al.
Publicado: (2022) -
SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination
por: Arora, Prerna, et al.
Publicado: (2022) -
Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes
por: Chatterjee, Debashree, et al.
Publicado: (2022) -
Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
por: Laiton-Donato, Katherine, et al.
Publicado: (2021) -
Active surveillance and early detection of community transmission of SARS‐CoV‐2 Mu variant (B.1.621) in the Brazilian Amazon
por: Oliveira, Gabriella S., et al.
Publicado: (2022)